Araştırma Makalesi

The prevalence of subclinical hypothyroidism in obese children and adolescents and its effects on metabolic parameters

Cilt: 41 Sayı: 4 31 Aralık 2019
PDF İndir
EN

The prevalence of subclinical hypothyroidism in obese children and adolescents and its effects on metabolic parameters

Abstract

Objective: To compare cardiovascular risk factors in obese patients with or without Subclinical Hypothyroidism (SH), also to estimate the prevalence of SH in obese children and adolescents.

Method: A total of 226 obese children and adolescents aged 6-18 years were included in the study. Two groups were created as euthyroid group (n=195) and SH group (n=31). After an 8-12 hour overnight fasting, serum blood glucose, insulin, HDL, LDL, cholesterol, triglyceride TSH, free T4, ALT, AST levels were measured. HOMA-IR and atherogenic index (AI) were calculated.

Results: Prevalence of SH was estimated as 14.1 %. The values of fasting glucose, fasting insülin, ALT, AST, TSH, HOMA-IR levels were significantly higher ın SH group than euthyroid group. There was a positive correlation between TSH and fasting glucose, insülin, triglyceride, ALT, AST, HOMA-IR, AI. It was also demonstrated that the TSH level was significantly and independently related to HOMA-IR value ın multiple regression analysis (p=0.001).

Conclusions: Obese patients with SH may be more susceptible to metabolic complications than euthyroid subjects.

Keywords

Kaynakça

  1. 1. Biondi B, Cooper DS: The clinical significance of subclinical thyroid dysfunction. Endocr.Rev. 2008; 29: 76-131
  2. 2. Salerno M, Capalbo D, Cerbone M, De LF: Subclinical hypothyroidism in childhood - current knowledge and open issues. Nat.Rev.Endocrinol. 2016; 12: 734-46
  3. 3. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC: Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann.Intern.Med. 2000; 132: 270-8
  4. 4. Diekman T, Lansberg PJ, Kastelein JJ, Wiersinga WM: Prevalence and correction of hypothyroidism in a large cohort of patients referred for dyslipidemia. Arch.Intern.Med. 1995; 155: 1490-5
  5. 5. Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, Burckhardt D, Girard J, Weintraub BD: Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am.J.Med. 1992; 92: 631-42
  6. 6. Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S: Thyroid hormones and cardiovascular disease. Nat.Rev.Cardiol. 2017; 14: 39-55
  7. 7. Bossowski A, Sawicka B, Szalecki M, Koput A, Wysocka J, Zelazowska-Rutkowska B: Analysis of serum adiponectin, resistin and leptin levels in children and adolescents with autoimmune thyroid disorders. J.Pediatr.Endocrinol.Metab 2010; 23: 369-77
  8. 8. Marwaha RK, Tandon N, Garg MK, Kanwar R, Sastry A, Narang A, Arora S, Bhadra K: Dyslipidemia in subclinical hypothyroidism in an Indian population. Clin.Biochem. 2011; 44: 1214-7

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık Kurumları Yönetimi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

31 Aralık 2019

Gönderilme Tarihi

8 Nisan 2019

Kabul Tarihi

31 Aralık 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 41 Sayı: 4

Kaynak Göster

AMA
1.Çelik N. The prevalence of subclinical hypothyroidism in obese children and adolescents and its effects on metabolic parameters. CMJ. 2019;41(4):691-697. doi:10.7197/cmj.vi.551051

Cited By